Silo Pharma Secures US Patent for Innovative PTSD Treatment and Gears Up for Clinical Trials
Silo Pharma, Inc. (Nasdaq: SILO), a biopharmaceutical company focused on developing novel therapies for psychiatric disorders, has recently received a Notice of Allowance from the...
